Crescita Therapeutics Inc (CTX) — Long-term Investment Intensity
Crescita Therapeutics Inc (CTX) has a Long-term Investment Intensity of 1.3% as of June 2025. Long-term investments of CA$293.00K represent 1.3% of total assets of CA$21.89 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Crescita Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Crescita Therapeutics Inc Long-term Investment Intensity (2021–2024)
This chart shows how Crescita Therapeutics Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the intensity stands at 1.3%, reflecting long-term investments of CA$293.00K against total assets of CA$21.89 Million CAD. For the complete balance sheet picture, see CTX total assets.
Annual Long-term Investment Intensity for Crescita Therapeutics Inc (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Crescita Therapeutics Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Crescita Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 1.4% | CA$311.00K | CA$21.78 Million | ▼ 0.0 pp |
| 2023 | 1.5% | CA$358.00K | CA$24.60 Million | ▲ +0.3 pp |
| 2022 | 1.2% | CA$342.00K | CA$28.48 Million | ▲ +0.0 pp |
| 2021 | 1.2% | CA$338.00K | CA$28.92 Million | — |